Health Technology/clinical-trials

Novel mHealth Trial Uses Smartphone GPS to Predict Bipolar Episodes in Veterans — Early Warning System Could Transform Care

247 Health News Editorial

·

27 Apr 2026

·

4 min read

·clinical-trials

The MEASURE-BD trial is pioneering smartphone GPS tracking to predict bipolar episodes in Veterans days before they occur. This innovative mHealth approach could transform bipolar care by providing early warning systems that don't rely on patient self-reporting.

Originally reported by ClinicalTrials.gov

References

  1. 1.VA Office of Research and Development. (2024). mHealth Estimate-based Algorithms Signaling Upcoming Recurrence of Episodes in Bipolar Disorders (MEASURE-BD). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06204705
  2. 2.Faurholt-Jepsen, M., Frost, M., Ritz, C., Christensen, E. M., Jacoby, A. S., Mikkelsen, R. L., Bardram, J., Vinberg, M., & Kessing, L. V. (2020). Daily electronic self-monitoring in bipolar disorder using smartphones - the MONARCA I trial: a randomized, placebo-controlled, single-blind, parallel group trial. Psychological Medicine, 50(5), 838-848. https://doi.org/10.1017/S0033291719000710
  3. 3.Gershon, A., & Eidelman, P. (2015). Inter-episode sleep and circadian rhythm disturbances in bipolar disorder. Current Psychiatry Reports, 17(10), 80. https://doi.org/10.1007/s11920-015-0617-9
  4. 4.Hidalgo-Mazzei, D., Mateu, A., Reinares, M., Matic, A., Vieta, E., & Colom, F. (2016). Smartphone apps for bipolar disorder: a systematic review of features and content quality. Journal of Medical Internet Research, 18(12), e318. https://doi.org/10.2196/jmir.5943
  5. 5.Merikangas, K. R., Jin, R., He, J. P., Kessler, R. C., Lee, S., Sampson, N. A., Vidal-Ribas, P., Georgiades, K., Lim, C. C., Gluzman, S., Navarro-Mateu, F., Pennell, B. E., Piazza, M., Posada-Villa, J., Sasu, C., Torres, Y., & Zarkov, Z. (2011). Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry, 68(3), 241-251. https://doi.org/10.1001/archgenpsychiatry.2011.12
  6. 6.Goodwin, G. M., Haddad, P. M., Ferrier, I. N., Aronson, J. K., Barnes, T., Cipriani, A., Coghill, D. R., Fazel, S., Geddes, J. R., Grunze, H., Holmes, E. A., Howes, O., Hudson, S., Hunt, N., Jones, I., Macmillan, I. C., McAllister-Williams, H., Miklowitz, D. R., Morriss, R., Munafò, M., Paton, C., Saharkian, B. J., Saunders, K., Sinclair, J., Taylor, D., Vieta, E., & Young, A. H. (2016). Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 30(6), 495-553. https://doi.org/10.1177/0269881116636545
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service